10 20 30 40 50 60 70 80 3KMU - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER CELL ADHESION 11-NOV-09 3KMU
TITLE CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (APO)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN-LINKED KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL PSEUDOKINASE DOMAIN: UNP RESIDUES 183- COMPND 5 452; COMPND 6 SYNONYM: ILK; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ALPHA-PARVIN; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: C-TERMINAL CALPONIN HOMOLOGY DOMAIN: UNP RESIDUES COMPND 13 248-372; COMPND 14 SYNONYM: CALPONIN-LIKE INTEGRIN-LINKED KINASE-BINDING COMPND 15 PROTEIN, CH-ILKBP, MATRIX-REMODELING-ASSOCIATED PROTEIN 2, COMPND 16 ACTOPAXIN; COMPND 17 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ILK, ILK1, ILK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PST39; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: PARVA, MXRA2; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PST39
KEYWDS CELL ADHESION, ANK REPEAT, ATP-BINDING, CELL JUNCTION, CELL KEYWDS 2 MEMBRANE, INTEGRIN-BINDING PROTEIN, MEMBRANE, NUCLEOTIDE- KEYWDS 3 BINDING, PHOSPHOPROTEIN, PSEUDOKINASE, ACTIN-BINDING, KEYWDS 4 ALTERNATIVE SPLICING
EXPDTA X-RAY DIFFRACTION
AUTHOR K.FUKUDA,J.QIN
REVDAT 1 29-DEC-09 3KMU 0
JRNL AUTH K.FUKUDA,S.GUPTA,K.CHEN,C.WU,J.QIN JRNL TITL THE PSEUDOACTIVE SITE OF ILK IS ESSENTIAL FOR ITS JRNL TITL 2 BINDING TO ALPHA-PARVIN AND LOCALIZATION TO FOCAL JRNL TITL 3 ADHESIONS. JRNL REF MOL.CELL V. 36 819 2009 JRNL REFN ISSN 1097-2765 JRNL PMID 20005845 JRNL DOI 10.1016/J.MOLCEL.2009.11.028
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 41751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2243 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3096 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 177 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3147 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.77000 REMARK 3 B22 (A**2) : -0.32000 REMARK 3 B33 (A**2) : -0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.06000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.124 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.642 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3230 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4382 ; 1.484 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 389 ; 5.536 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;34.393 ;24.041 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 568 ;14.759 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;19.087 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 484 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2442 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1582 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2237 ; 0.307 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 272 ; 0.172 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 44 ; 0.163 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.206 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2009 ; 1.094 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3201 ; 1.727 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1366 ; 2.809 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1181 ; 3.853 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED IN REMARK 3 PHASING
REMARK 4 REMARK 4 3KMU COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-NOV-09. REMARK 100 THE RCSB ID CODE IS RCSB056188.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97880, 0.97900 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 94370 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 58.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 28.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M BIS-TRIS, 12% PEG 5000 MME, REMARK 280 5% 1-PROPYL ALCOHOL, PH 6.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 58.85750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE HETERODIMERIC COMPLEX OBSERVED IN THE ASYMMETRIC REMARK 300 UNIT IS RELEVANT TO THE BIOLOGICAL ASSEMBLY UNIT IN VIVO.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -1 REMARK 465 ASN A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 452 REMARK 465 GLY B -4 REMARK 465 SER B -3 REMARK 465 HIS B -2 REMARK 465 MSE B -1 REMARK 465 ASP B 248
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE A 337 SE MSE A 337 CE -0.402 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 257 68.98 -153.38 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KMW RELATED DB: PDB REMARK 900 CYTOSKELETAL PROTEIN COMPLEX 2
DBREF 3KMU A 183 452 UNP Q13418 ILK_HUMAN 183 452 DBREF 3KMU B 248 372 UNP Q9NVD7 PARVA_HUMAN 248 372
SEQADV 3KMU MSE A -1 UNP Q13418 EXPRESSION TAG SEQADV 3KMU SER A 346 UNP Q13418 CYS 346 ENGINEERED SEQADV 3KMU SER A 422 UNP Q13418 CYS 422 ENGINEERED SEQADV 3KMU GLY B -4 UNP Q9NVD7 EXPRESSION TAG SEQADV 3KMU SER B -3 UNP Q9NVD7 EXPRESSION TAG SEQADV 3KMU HIS B -2 UNP Q9NVD7 EXPRESSION TAG SEQADV 3KMU MSE B -1 UNP Q9NVD7 EXPRESSION TAG
SEQRES 1 A 271 MSE ASN LYS HIS SER GLY ILE ASP PHE LYS GLN LEU ASN SEQRES 2 A 271 PHE LEU THR LYS LEU ASN GLU ASN HIS SER GLY GLU LEU SEQRES 3 A 271 TRP LYS GLY ARG TRP GLN GLY ASN ASP ILE VAL VAL LYS SEQRES 4 A 271 VAL LEU LYS VAL ARG ASP TRP SER THR ARG LYS SER ARG SEQRES 5 A 271 ASP PHE ASN GLU GLU CYS PRO ARG LEU ARG ILE PHE SER SEQRES 6 A 271 HIS PRO ASN VAL LEU PRO VAL LEU GLY ALA CYS GLN SER SEQRES 7 A 271 PRO PRO ALA PRO HIS PRO THR LEU ILE THR HIS TRP MSE SEQRES 8 A 271 PRO TYR GLY SER LEU TYR ASN VAL LEU HIS GLU GLY THR SEQRES 9 A 271 ASN PHE VAL VAL ASP GLN SER GLN ALA VAL LYS PHE ALA SEQRES 10 A 271 LEU ASP MSE ALA ARG GLY MSE ALA PHE LEU HIS THR LEU SEQRES 11 A 271 GLU PRO LEU ILE PRO ARG HIS ALA LEU ASN SER ARG SER SEQRES 12 A 271 VAL MSE ILE ASP GLU ASP MSE THR ALA ARG ILE SER MSE SEQRES 13 A 271 ALA ASP VAL LYS PHE SER PHE GLN SER PRO GLY ARG MSE SEQRES 14 A 271 TYR ALA PRO ALA TRP VAL ALA PRO GLU ALA LEU GLN LYS SEQRES 15 A 271 LYS PRO GLU ASP THR ASN ARG ARG SER ALA ASP MSE TRP SEQRES 16 A 271 SER PHE ALA VAL LEU LEU TRP GLU LEU VAL THR ARG GLU SEQRES 17 A 271 VAL PRO PHE ALA ASP LEU SER ASN MSE GLU ILE GLY MSE SEQRES 18 A 271 LYS VAL ALA LEU GLU GLY LEU ARG PRO THR ILE PRO PRO SEQRES 19 A 271 GLY ILE SER PRO HIS VAL SER LYS LEU MSE LYS ILE CYS SEQRES 20 A 271 MSE ASN GLU ASP PRO ALA LYS ARG PRO LYS PHE ASP MSE SEQRES 21 A 271 ILE VAL PRO ILE LEU GLU LYS MSE GLN ASP LYS SEQRES 1 B 129 GLY SER HIS MSE ASP ALA PHE ASP THR LEU PHE ASP HIS SEQRES 2 B 129 ALA PRO ASP LYS LEU ASN VAL VAL LYS LYS THR LEU ILE SEQRES 3 B 129 THR PHE VAL ASN LYS HIS LEU ASN LYS LEU ASN LEU GLU SEQRES 4 B 129 VAL THR GLU LEU GLU THR GLN PHE ALA ASP GLY VAL TYR SEQRES 5 B 129 LEU VAL LEU LEU MSE GLY LEU LEU GLU GLY TYR PHE VAL SEQRES 6 B 129 PRO LEU HIS SER PHE PHE LEU THR PRO ASP SER PHE GLU SEQRES 7 B 129 GLN LYS VAL LEU ASN VAL SER PHE ALA PHE GLU LEU MSE SEQRES 8 B 129 GLN ASP GLY GLY LEU GLU LYS PRO LYS PRO ARG PRO GLU SEQRES 9 B 129 ASP ILE VAL ASN CYS ASP LEU LYS SER THR LEU ARG VAL SEQRES 10 B 129 LEU TYR ASN LEU PHE THR LYS TYR ARG ASN VAL GLU
MODRES 3KMU MSE A 272 MET SELENOMETHIONINE MODRES 3KMU MSE A 301 MET SELENOMETHIONINE MODRES 3KMU MSE A 305 MET SELENOMETHIONINE MODRES 3KMU MSE A 326 MET SELENOMETHIONINE MODRES 3KMU MSE A 331 MET SELENOMETHIONINE MODRES 3KMU MSE A 337 MET SELENOMETHIONINE MODRES 3KMU MSE A 350 MET SELENOMETHIONINE MODRES 3KMU MSE A 375 MET SELENOMETHIONINE MODRES 3KMU MSE A 398 MET SELENOMETHIONINE MODRES 3KMU MSE A 402 MET SELENOMETHIONINE MODRES 3KMU MSE A 425 MET SELENOMETHIONINE MODRES 3KMU MSE A 429 MET SELENOMETHIONINE MODRES 3KMU MSE A 441 MET SELENOMETHIONINE MODRES 3KMU MSE A 449 MET SELENOMETHIONINE MODRES 3KMU MSE B 300 MET SELENOMETHIONINE MODRES 3KMU MSE B 334 MET SELENOMETHIONINE
HET MSE A 272 8 HET MSE A 301 8 HET MSE A 305 8 HET MSE A 326 8 HET MSE A 331 8 HET MSE A 337 8 HET MSE A 350 8 HET MSE A 375 8 HET MSE A 398 8 HET MSE A 402 8 HET MSE A 425 8 HET MSE A 429 8 HET MSE A 441 8 HET MSE A 449 8 HET MSE B 300 8 HET MSE B 334 8
HETNAM MSE SELENOMETHIONINE
FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 HOH *298(H2 O)
HELIX 1 1 ASP A 189 LEU A 193 5 5 HELIX 2 2 SER A 228 CYS A 239 1 12 HELIX 3 3 PRO A 240 ARG A 243 5 4 HELIX 4 4 SER A 276 GLU A 283 1 8 HELIX 5 5 ASP A 290 HIS A 309 1 20 HELIX 6 6 ALA A 338 VAL A 340 5 3 HELIX 7 7 ALA A 352 VAL A 356 5 5 HELIX 8 8 ALA A 357 LYS A 363 1 7 HELIX 9 9 LYS A 364 THR A 368 5 5 HELIX 10 10 ASN A 369 ARG A 388 1 20 HELIX 11 11 SER A 396 GLU A 407 1 12 HELIX 12 12 SER A 418 MSE A 429 1 12 HELIX 13 13 ASP A 432 ARG A 436 5 5 HELIX 14 14 LYS A 438 GLN A 450 1 13 HELIX 15 15 ALA B 249 HIS B 256 1 8 HELIX 16 16 ALA B 257 ASN B 277 1 21 HELIX 17 17 LYS B 278 ASN B 280 5 3 HELIX 18 18 GLY B 293 GLY B 305 1 13 HELIX 19 19 PRO B 309 PHE B 313 5 5 HELIX 20 20 SER B 319 GLY B 337 1 19 HELIX 21 21 ARG B 345 ASN B 351 1 7 HELIX 22 22 ASP B 353 ARG B 369 1 17
SHEET 1 A 5 ASN A 194 ASN A 202 0 SHEET 2 A 5 GLY A 205 TRP A 212 -1 O LYS A 209 N THR A 197 SHEET 3 A 5 ASN A 215 LEU A 222 -1 O VAL A 221 N GLU A 206 SHEET 4 A 5 THR A 266 HIS A 270 -1 O LEU A 267 N LYS A 220 SHEET 5 A 5 GLY A 255 CYS A 257 -1 N CYS A 257 O THR A 266 SHEET 1 B 3 VAL A 250 LEU A 251 0 SHEET 2 B 3 ALA A 333 SER A 336 1 O ILE A 335 N LEU A 251 SHEET 3 B 3 VAL A 325 ILE A 327 -1 N MSE A 326 O ARG A 334
LINK C MSE A 272 N PRO A 273 1555 1555 1.34 LINK C MSE A 301 N ALA A 302 1555 1555 1.33 LINK C MSE A 305 N ALA A 306 1555 1555 1.34 LINK C MSE A 326 N ILE A 327 1555 1555 1.34 LINK C MSE A 331 N THR A 332 1555 1555 1.32 LINK C MSE A 337 N ALA A 338 1555 1555 1.34 LINK C MSE A 350 N TYR A 351 1555 1555 1.33 LINK C MSE A 375 N TRP A 376 1555 1555 1.34 LINK C MSE A 398 N GLU A 399 1555 1555 1.33 LINK C MSE A 402 N LYS A 403 1555 1555 1.33 LINK C MSE A 425 N LYS A 426 1555 1555 1.33 LINK C MSE A 429 N ASN A 430 1555 1555 1.32 LINK C MSE A 441 N ILE A 442 1555 1555 1.32 LINK C MSE A 449 N GLN A 450 1555 1555 1.32 LINK C MSE B 300 N GLY B 301 1555 1555 1.33 LINK C MSE B 334 N GLN B 335 1555 1555 1.33 LINK C TRP A 271 N MSE A 272 1555 1555 1.32 LINK C ASP A 300 N MSE A 301 1555 1555 1.34 LINK C GLY A 304 N MSE A 305 1555 1555 1.34 LINK C VAL A 325 N MSE A 326 1555 1555 1.33 LINK C ASP A 330 N MSE A 331 1555 1555 1.34 LINK C SER A 336 N MSE A 337 1555 1555 1.32 LINK C ARG A 349 N MSE A 350 1555 1555 1.34 LINK C ASP A 374 N MSE A 375 1555 1555 1.33 LINK C ASN A 397 N MSE A 398 1555 1555 1.34 LINK C GLY A 401 N MSE A 402 1555 1555 1.33 LINK C LEU A 424 N MSE A 425 1555 1555 1.33 LINK C CYS A 428 N MSE A 429 1555 1555 1.33 LINK C ASP A 440 N MSE A 441 1555 1555 1.34 LINK C LYS A 448 N MSE A 449 1555 1555 1.34 LINK C LEU B 299 N MSE B 300 1555 1555 1.34 LINK C LEU B 333 N MSE B 334 1555 1555 1.33
CISPEP 1 SER A 259 PRO A 260 0 0.81 CISPEP 2 PRO A 260 PRO A 261 0 1.98 CISPEP 3 GLU A 312 PRO A 313 0 -2.56
CRYST1 44.380 117.715 47.344 90.00 101.68 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022533 0.000000 0.004658 0.00000
SCALE2 0.000000 0.008495 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021569 0.00000